Crafting a Better T Cell for Immunotherapy (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

T-cell therapy, a form of immunotherapy that uses a patient's own immune cells to attack their cancer, has been making waves recently. The 'living' therapy involves engineering the patient's T cells in the laboratory to carry new proteins that guide the immune cells directly to tumor cells, allowing the engineered T cells to attack and kill the cancer. While still experimental, the therapy currently takes between 2 and 3 weeks for researchers to harvest a patient's T cells and turn them into ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news